title: Etoposide (VP-16-213). Current status of an active anticancer drug.
authors.forename: P J
authors.initials: PJ
authors.lastname: O'Dwyer
authors.forename: B
authors.initials: B
authors.lastname: Leyland-Jones
authors.forename: M T
authors.initials: MT
authors.lastname: Alonso
authors.forename: S
authors.initials: S
authors.lastname: Marsoni
authors.forename: R E
authors.initials: RE
authors.lastname: Wittes
mesh_terms: D000818:Animals; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004247:DNA / Q000378:metabolism; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D005047:Etoposide / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D051379:Mice; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013736:Testicular Neoplasms / Q000188:drug therapy; D014018:Tissue Distribution
chemical_list: D005047:Etoposide; D004247:DNA; D011034:Podophyllotoxin